Page last updated: 2024-11-05

trinitrosotrimethylenetriamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID26368
CHEMBL ID352556
CHEBI ID24557
SCHEMBL ID3464027
MeSH IDM0062601

Synonyms (31)

Synonym
1,3,5-triazine, hexahydro-1,3,5-trinitroso-
13980-04-6
hexahydro-1,3,5-trinitroso-1,3,5-triazine
CHEBI:24557 ,
1,3,5-trinitroso-1,3,5-triazinane
trinitrosotrimethylenetriamine
trinitrosotrimethylentriamin [german]
brn 0014853
hexahydro-1,3,5-trinitroso-s-triazine
s-triazine, hexahydro-1,3,5-trinitroso-
einecs 237-766-2
hexahydro-1,3,5-s-triazine
1,3,5-trinitrosohexahydro-s-triazine
CHEMBL352556
1,3,5-trinitroso-[1,3,5]triazinane
AKOS006275535
ccris 9502
trinitrosotrimethylentriamin
tnx cpd
mk86fr3sn8 ,
4-26-00-00018 (beilstein handbook reference)
unii-mk86fr3sn8
SCHEMBL3464027
HFWOSHMLDRSIDN-UHFFFAOYSA-N
1,3,5-trinitroso-1,3,5-triazine, hexahydro-
1,3,5-trinitroso-1,3,5-triazinane #
n,n',n''-trinitroso-1,3,5-hexahydrotriazine
DTXSID10161171
Q27109843
mfcd00463950
SY271763

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" LC20 and LC50 for TNX were slightly lower than for MNX; this indicates that TNX was more toxic than MNX."( Toxicity of the explosive metabolites hexahydro-1,3,5-trinitroso-1,3,5-triazine (TNX) and hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine (MNX) to the earthworm Eisenia fetida.
Anderson, TA; Kendall, RJ; Zhang, B, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
1,3,5-triazinanes
nitrosamineN-Nitroso amines, compounds of the structure R2NNO. Compounds RNHNO are not ordinarily isolable, but they, too, are nitrosamines. The name is a contraction of N-nitrosoamine and, as such, does not require the N locant.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226733Carcinogenic potency modelled in silico, (- = non-carcinogen)1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.89 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]